JPS645005B2 - - Google Patents
Info
- Publication number
- JPS645005B2 JPS645005B2 JP53102370A JP10237078A JPS645005B2 JP S645005 B2 JPS645005 B2 JP S645005B2 JP 53102370 A JP53102370 A JP 53102370A JP 10237078 A JP10237078 A JP 10237078A JP S645005 B2 JPS645005 B2 JP S645005B2
- Authority
- JP
- Japan
- Prior art keywords
- polymer
- microcapsules
- isopropanol
- solvent
- microspheres
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000004005 microsphere Substances 0.000 claims description 28
- 239000011162 core material Substances 0.000 claims description 24
- 229920002988 biodegradable polymer Polymers 0.000 claims description 6
- 239000004621 biodegradable polymer Substances 0.000 claims description 6
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 claims description 3
- 229960002802 bromocriptine Drugs 0.000 claims description 3
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 3
- 239000004626 polylactic acid Substances 0.000 claims description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 56
- 229920000642 polymer Polymers 0.000 description 55
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 40
- 239000002904 solvent Substances 0.000 description 39
- 239000003094 microcapsule Substances 0.000 description 37
- 239000003814 drug Substances 0.000 description 31
- 229940079593 drug Drugs 0.000 description 31
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 30
- 238000000034 method Methods 0.000 description 28
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 239000002245 particle Substances 0.000 description 16
- 239000003795 chemical substances by application Substances 0.000 description 13
- 239000012071 phase Substances 0.000 description 12
- 238000005191 phase separation Methods 0.000 description 12
- 229920001244 Poly(D,L-lactide) Polymers 0.000 description 10
- 239000006185 dispersion Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 238000007710 freezing Methods 0.000 description 8
- 230000008014 freezing Effects 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 230000002776 aggregation Effects 0.000 description 7
- 239000002775 capsule Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000005054 agglomeration Methods 0.000 description 6
- GGNALUCSASGNCK-UHFFFAOYSA-N carbon dioxide;propan-2-ol Chemical compound O=C=O.CC(C)O GGNALUCSASGNCK-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 5
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 5
- -1 flavorings Substances 0.000 description 4
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 239000002861 polymer material Substances 0.000 description 4
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 235000011089 carbon dioxide Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000012456 homogeneous solution Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920000954 Polyglycolide Polymers 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- KLBQZWRITKRQQV-UHFFFAOYSA-N Thioridazine Chemical compound C12=CC(SC)=CC=C2SC2=CC=CC=C2N1CCC1CCCCN1C KLBQZWRITKRQQV-UHFFFAOYSA-N 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229920001688 coating polymer Polymers 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 229940088679 drug related substance Drugs 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 239000008240 homogeneous mixture Substances 0.000 description 2
- 229940035429 isobutyl alcohol Drugs 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000004633 polyglycolic acid Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- AJDIZQLSFPQPEY-UHFFFAOYSA-N 1,1,2-Trichlorotrifluoroethane Chemical compound FC(F)(Cl)C(F)(Cl)Cl AJDIZQLSFPQPEY-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 229960000807 dihydroergotamine mesylate Drugs 0.000 description 1
- ADYPXRFPBQGGAH-UMYZUSPBSA-N dihydroergotamine mesylate Chemical compound CS(O)(=O)=O.C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2[C@@H](C=3C=CC=C4NC=C(C=34)C2)C1)C)C1=CC=CC=C1 ADYPXRFPBQGGAH-UMYZUSPBSA-N 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000002194 freeze distillation Methods 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000006069 physical mixture Substances 0.000 description 1
- JZQKKSLKJUAGIC-UHFFFAOYSA-N pindolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=C1C=CN2 JZQKKSLKJUAGIC-UHFFFAOYSA-N 0.000 description 1
- 229960002508 pindolol Drugs 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 239000003128 rodenticide Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229960002784 thioridazine Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
- A01N25/28—Microcapsules or nanocapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/025—Explicitly spheroidal or spherical shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/85—Polyesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q13/00—Formulations or additives for perfume preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/08—Simple coacervation, i.e. addition of highly hydrophilic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/61—Surface treated
- A61K2800/62—Coated
- A61K2800/624—Coated by macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/65—Characterized by the composition of the particulate/core
- A61K2800/654—The particulate/core comprising macromolecular material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dentistry (AREA)
- Dispersion Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82771077A | 1977-08-25 | 1977-08-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5455717A JPS5455717A (en) | 1979-05-04 |
| JPS645005B2 true JPS645005B2 (fr) | 1989-01-27 |
Family
ID=25249947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10237078A Granted JPS5455717A (en) | 1977-08-25 | 1978-08-24 | Minute globules and production |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS5455717A (fr) |
| AT (1) | AT372019B (fr) |
| AU (1) | AU522215B2 (fr) |
| BE (1) | BE869915A (fr) |
| CA (1) | CA1122077A (fr) |
| CH (2) | CH649217A5 (fr) |
| DE (1) | DE2836044A1 (fr) |
| DK (2) | DK361878A (fr) |
| ES (1) | ES472800A1 (fr) |
| FI (1) | FI64899C (fr) |
| FR (1) | FR2400950A1 (fr) |
| GB (1) | GB2003108B (fr) |
| IE (1) | IE47255B1 (fr) |
| IL (1) | IL55418A (fr) |
| IT (1) | IT1098111B (fr) |
| NL (1) | NL7808613A (fr) |
| NZ (1) | NZ188232A (fr) |
| PH (1) | PH15447A (fr) |
| PT (1) | PT68473A (fr) |
| SE (1) | SE431942B (fr) |
| ZA (1) | ZA784855B (fr) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6045845B2 (ja) * | 1979-10-31 | 1985-10-12 | 田辺製薬株式会社 | 医薬物質含有マイクロカプセルの製法 |
| US4384975A (en) * | 1980-06-13 | 1983-05-24 | Sandoz, Inc. | Process for preparation of microspheres |
| PH19942A (en) * | 1980-11-18 | 1986-08-14 | Sintex Inc | Microencapsulation of water soluble polypeptides |
| DE3045135A1 (de) * | 1980-11-29 | 1982-06-09 | Sandoz-Patent-GmbH, 7850 Lörrach | Pharmazeutische kompositionen enthaltende bioabbaubare polymere |
| JPS5933214A (ja) * | 1982-08-19 | 1984-02-23 | Mitsui Toatsu Chem Inc | 微小球に製剤された制ガン剤の製造方法 |
| AT382076B (de) * | 1982-10-15 | 1987-01-12 | Chemie Linz Ag | Verfahren zur herstellung von presslingen mit retardierter wirkstofffreisetzung |
| DE3417576A1 (de) * | 1984-05-11 | 1985-11-14 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | Retardformen des alpha-(2,5-dimethoxy-phenyl)-ss-glycinamidoaethanols und verfahren zu ihrer herstellung |
| DE3428372A1 (de) * | 1984-08-01 | 1986-02-13 | Hoechst Ag, 6230 Frankfurt | Mikrokapseln von regulatorischen peptiden mit kontrollierter freisetzung, verfahren zu ihrer herstellung und injektionszubereitungen |
| CH660302A5 (fr) * | 1984-10-17 | 1987-04-15 | Debiopharm Sa | Procede de micro-encapsulation en phase heterogene de substances medicamenteuses hydrosolubles. |
| CH669506A5 (en) * | 1986-01-13 | 1989-03-31 | Hugo Degen | Oscillating and reclining furniture |
| DE3712095A1 (de) * | 1987-04-10 | 1988-10-20 | Lentia Gmbh | Bindemittelfreies granulat mit verzoegerter wirkstoffabgabe |
| US4861627A (en) * | 1987-05-01 | 1989-08-29 | Massachusetts Institute Of Technology | Preparation of multiwall polymeric microcapsules |
| HU221294B1 (en) * | 1989-07-07 | 2002-09-28 | Novartis Ag | Process for producing retarde compositions containing the active ingredient in a polymeric carrier |
| FR2657255B1 (fr) * | 1989-12-27 | 1992-04-24 | Sederma Sa | Description de preparations cosmetiques originales dont les principes actifs sont pieges dans un reseau polymerique greffe a la surface de particules de silice. |
| DE4127757A1 (de) * | 1991-02-06 | 1992-08-13 | Hoechst Ag | Neue pflanzenschutzmittel-formulierungen |
| US6204308B1 (en) | 1999-03-01 | 2001-03-20 | Novartis Ag | Organic compounds |
| EP1303387B1 (fr) | 2000-05-12 | 2006-06-28 | Matregen Corp. | Procede permettant de produire des structures a l'aide de forces centrifuges |
| US6969480B2 (en) | 2000-05-12 | 2005-11-29 | Matregen Corp. | Method of producing structures using centrifugal forces |
| US6824822B2 (en) * | 2001-08-31 | 2004-11-30 | Alkermes Controlled Therapeutics Inc. Ii | Residual solvent extraction method and microparticles produced thereby |
| EP2219775A4 (fr) * | 2007-12-11 | 2012-10-03 | Univ Nanyang Tech | Microsphères creuses multicouches pour l'administration de composés actifs hydrophiles |
| KR101294925B1 (ko) | 2008-05-21 | 2013-08-08 | 도레이 카부시키가이샤 | 중합체 미립자의 제조 방법 |
| CN103828801B (zh) * | 2014-01-15 | 2016-01-27 | 福建农林大学 | 多杀菌素/甲氨基阿维菌素苯甲酸盐微球及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT631615A (fr) * | 1960-02-26 | |||
| US3427250A (en) * | 1963-03-25 | 1969-02-11 | Polaroid Corp | Microscopic capsules and process for their preparation |
| US3531418A (en) * | 1965-08-18 | 1970-09-29 | Ncr Co | En masse encapsulation process |
| FR1497584A (fr) * | 1966-08-11 | 1967-10-13 | Roussel Uclaf | Procédé de fabrication de microcapsules |
| US3703474A (en) * | 1967-08-21 | 1972-11-21 | Ncr Co | Encapsulation process |
| US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| JPS51125675A (en) * | 1975-02-13 | 1976-11-02 | Asahi Chem Ind Co Ltd | A porous capsule structvre and a process for manufacturing turing it |
-
1978
- 1978-08-15 CH CH310/84A patent/CH649217A5/de not_active IP Right Cessation
- 1978-08-15 CH CH867978A patent/CH644768A5/de not_active IP Right Cessation
- 1978-08-16 DK DK361878A patent/DK361878A/da not_active Application Discontinuation
- 1978-08-16 FI FI782501A patent/FI64899C/fi not_active IP Right Cessation
- 1978-08-17 DE DE19782836044 patent/DE2836044A1/de active Granted
- 1978-08-18 SE SE7808759A patent/SE431942B/sv unknown
- 1978-08-21 NL NL7808613A patent/NL7808613A/xx active Search and Examination
- 1978-08-22 GB GB7834199A patent/GB2003108B/en not_active Expired
- 1978-08-23 BE BE190031A patent/BE869915A/fr not_active IP Right Cessation
- 1978-08-23 IT IT26961/78A patent/IT1098111B/it active
- 1978-08-23 CA CA000309884A patent/CA1122077A/fr not_active Expired
- 1978-08-23 ES ES472800A patent/ES472800A1/es not_active Expired
- 1978-08-23 NZ NZ188232A patent/NZ188232A/xx unknown
- 1978-08-23 IE IE1708/78A patent/IE47255B1/en unknown
- 1978-08-23 AT AT0612478A patent/AT372019B/de not_active IP Right Cessation
- 1978-08-23 IL IL55418A patent/IL55418A/xx unknown
- 1978-08-24 JP JP10237078A patent/JPS5455717A/ja active Granted
- 1978-08-24 PT PT68473A patent/PT68473A/fr unknown
- 1978-08-24 AU AU39236/78A patent/AU522215B2/en not_active Expired
- 1978-08-24 FR FR7824597A patent/FR2400950A1/fr active Granted
- 1978-08-25 PH PH21539A patent/PH15447A/en unknown
- 1978-08-25 ZA ZA784855A patent/ZA784855B/xx unknown
-
1989
- 1989-12-07 DK DK618189A patent/DK618189D0/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AT372019B (de) | 1983-08-25 |
| IE781708L (en) | 1979-02-25 |
| IE47255B1 (en) | 1984-02-08 |
| DK618189A (da) | 1989-12-07 |
| FR2400950A1 (fr) | 1979-03-23 |
| FI64899C (fi) | 1984-02-10 |
| SE7808759L (sv) | 1979-02-26 |
| DK361878A (da) | 1979-02-26 |
| FI64899B (fi) | 1983-10-31 |
| CA1122077A (fr) | 1982-04-20 |
| SE431942B (sv) | 1984-03-12 |
| PT68473A (fr) | 1978-09-01 |
| FR2400950B1 (fr) | 1983-10-07 |
| IT7826961A0 (it) | 1978-08-23 |
| CH649217A5 (de) | 1985-05-15 |
| ATA612478A (de) | 1983-01-15 |
| AU522215B2 (en) | 1982-05-20 |
| AU3923678A (en) | 1980-02-28 |
| ES472800A1 (es) | 1979-10-16 |
| JPS5455717A (en) | 1979-05-04 |
| DE2836044A1 (de) | 1979-03-01 |
| PH15447A (en) | 1983-01-18 |
| ZA784855B (en) | 1980-04-30 |
| BE869915A (fr) | 1979-02-23 |
| NL7808613A (nl) | 1979-02-27 |
| CH644768A5 (de) | 1984-08-31 |
| IL55418A0 (en) | 1978-10-31 |
| DK618189D0 (da) | 1989-12-07 |
| FI782501A (fi) | 1979-02-26 |
| GB2003108B (en) | 1982-03-24 |
| NZ188232A (en) | 1980-12-19 |
| IT1098111B (it) | 1985-09-07 |
| DE2836044C2 (fr) | 1988-06-23 |
| GB2003108A (en) | 1979-03-07 |
| IL55418A (en) | 1981-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS645005B2 (fr) | ||
| US4166800A (en) | Processes for preparation of microspheres | |
| US4861627A (en) | Preparation of multiwall polymeric microcapsules | |
| AU699080B2 (en) | Sustained release particles | |
| Singh et al. | Microencapsulation: A promising technique for controlled drug delivery | |
| Bodmeier et al. | Solvent selection in the preparation of poly (DL-lactide) microspheres prepared by the solvent evaporation method | |
| EP1289645B1 (fr) | Microcapsules a liberation d'ordre nul et commande par la temperature, et procede pour leur elaboration | |
| CA1218306A (fr) | Preparation de microparticules injectables a action prolongee pour la dispensation d'agents anti- inflammatoires | |
| KR860001561B1 (ko) | 마이크로 캪슐과 그 제조방법 | |
| US4615881A (en) | Pharmaceutical compositions | |
| WO1997022409A1 (fr) | Microcapsules en polymere creux et procede de fabrication | |
| WO1999002140A1 (fr) | Procede de preparation de forme posologique solide a dispersion rapide, a administrer par voie orale | |
| JPS6045223B2 (ja) | 二酸化珪素含有組成物及びその製造方法 | |
| Bodmeier et al. | Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. II. W/O/W multiple emulsion technique for water-soluble drugs | |
| JP2000511110A (ja) | 超臨界流体を使用したマイクロカプセル化方法 | |
| US4107071A (en) | Method of producing microcapsules and resulting product | |
| JPH10511596A (ja) | 封入された活性材料及びその製造方法 | |
| PL212531B1 (pl) | Kompozycja o przedluzonym uwalnianiu leuproreliny, sposób wytwarzania kompozycji, srodek farmaceutyczny zawierajacy kompozycje i zastosowanie kompozycji, sposób wytwarzania polimeru kwasu mlekowego i kwasu glikolowego i zastosowanie polimeru | |
| Miyazaki et al. | Effect of temperature-increase rate on drug release characteristics of dextran microspheres prepared by emulsion solvent evaporation process | |
| Pekarek et al. | One‐step preparation of double‐walled microspheres | |
| Garg et al. | Microencapsulation techniques in pharmaceutical formulation | |
| US4464434A (en) | Microencapsulated alkaloidal material and method of producing same | |
| Ribardiere et al. | Modification of ketoprofen bead structure produced by the spherical crystallization technique with a two-solvent system | |
| Preda et al. | Oxprenolol-loaded bioadhesive microspheres: preparation and in vitro/in vivo characterization | |
| KR100341261B1 (ko) | 건조가공입자의제조방법,그로부터얻어진건조가공입자및이들입자를함유하는제약조성물 |